RAPT — Rapt Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $276.66m
- $117.80m
- 30
- 20
- 15
- 10
Annual cashflow statement for Rapt Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -43 | -52.9 | -69.2 | -83.8 | -117 |
| Depreciation | |||||
| Non-Cash Items | 2.06 | 8.93 | 11.5 | 13.4 | 13 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 4.13 | 2.34 | -4.3 | -1.33 | 5.5 |
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -35.5 | -40.5 | -61 | -70.8 | -97 |
| Capital Expenditures | -0.888 | -0.398 | -0.755 | -0.845 | -1.13 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.045 | -87 | -80.6 | -44.6 | 105 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -0.843 | -87.4 | -81.3 | -45.5 | 104 |
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 49.9 | 75.5 | 141 | 131 | 1.45 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 13.6 | -52.5 | -0.891 | 14.9 | 8.53 |